Table Of Content

2 Molecular and Cellular Biochemistry 274: 207-209, 2005 Index to Volume 274 Ackermann K, see Pyerin W eta l Ackermann K, Neidhart T, Gerber J, Waxmann A, Pyerin W: The catalytic subunit @ gene of human protein kinase CK2 (CSNK2A2): Genomic organization, promoter identification and determination of Ets! as a key regulator Ahmad KA, see Wang G et al Ahmad KA, see Wang G et al Ahmed K, see Wang Getal Ahmed K, see Wang G et al Allada R, Meissner R-A: Casein kinase 2, circadian clocks, and the flight from mutagenic light 141-149 Allende JE, see Hermosilla GH et al Allende-Vega N, Dias S, Milne D, Meek D: Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2 85-90 Bandhakavi S, see Poole A et al 3arz T, see Pyerin W et al Bidwai AP, see Karandikar UC er al Bishop CP, see Karandikar UC er al Blond O, Jensen HH, Buchou T, Cochet C, Issinger O-G, Boldyreff B: Knocking out the regulatory beta subunit of protein kinase CK2 in mice: Gene dosage effects in ES cells and embryos Boldyreff B, see Blond O et al Boldyreff B, see Rasmussen T eta l Buchou T, see Blond O et al Cochet C, see Blond O et al Cochet C, see Theis-Febvre N et al Cozza G, see Pagano MA et al Currier N, see Seldin DC et al Dias S, see Allende-Vega N eta l Dominguez I, see Seldin DC et al Dominguez I, Mizuno J, Wu H, Imbrie GA, Symes K, Seldin DC: A role for CK2a@/f in Xenopus early embryonic development Duarri A, see Llorens F et al Farago M, see Seldin DC et al Filhol O, see Theis-Febvre N et al Frascella P, see Sarno S et al Gotz C, Kartarius S, Schetting S, Montenarh M: Immunologically defined subclasses of the protein kinase CK2 £-subunit in prostate carcinoma cell lines Gerber J, see Ackermann K et al Gilmour SK, see Lawson K et al Glever CVC, see Poole A et al Grunwald D, see Theis-Febvre N et al Hanna DE, see Poole A et al Hermosilla GH, Tapia JC, Allende JE: Minimal CK2 activity required for yeast growth Homma MK, Homma Y: Regulatory role of CK2 during the progression of cell cycle Homma Y, see Homma MK et? al Imbrie GA, see Dominguez | et al Issinger O-G, see Blond O et al Issinger O-G, see Niefind K et al Issinger O-G, see Rasmussen T et al Itarte E, see Llorens F et al Jensen HH, see Blond O ef al Jensen HH, see Rasmussen T et al Karandikar UC, Shaffer J, Bishop CP, Bidwai AP: Drosophila CK2 phosphorylates Deadpan, a member of the HES family of basic-helix-loop-helix (bHLH) repressors 208 Kartarius S, see Gotz C et al andesman-Bollag E, see Seldin DC et al arentowicz L, see Lawson K et al audet B, see Theis-Febvre N et a iury-Kleintop L, see Lawson K et a awson K, Larentowicz L, Laury-Kleintop L, Gilmour SK: B23 is a downstream target of polyamine-modulated CK2 itchfielDdW , see OlstenM EKe t « lorens F, Sarno S, Sarré E, Duarri A, Roher N, Meggio F, Plana M, Pinna LA, Itarte E: Cross talk between protein kinase CK2 and eukaryotic translation initiation factor el[F2£ subunit LouD , see SeldinD C eta l Lucchini V, see Sarno S et a Maira GD, see SarnS oet a Martel V, see Theis-FebNv rete a i Mazzorana M, see Sarn§ eot a McCann RO, see Poole A et al Meek D, see Allende-Vega N et ai Meggio F, see LlorensF et ai Meggio F, see PagaMnA oet a Meggio F, see SarSn eot al Meissner R-A, see Allada R et al MilneD , see Allende-VNe egta a l Miyata Y, Nishida E: CK2 binds, phosphorylates, and regulates its pivotal substrate Cdc37, an Hsp90-cochaperone Mizuno J, see Dominguez |e t a Montenarh M, see Gotz C et a Neidhart T, see Ackermann K et al Niefind K, Issinger O-G: Primary and secondary interactions between CK2a@ and CK28 lead to ring-like structures in the crystals of the CK2 holoenzyme Niefind K, see Rasmussen T ef Nishida E, see MiyataY et al Olsten MEK, Weber JE, Litchfield DW: CK2 interacting proteins: Emerging paradigms for CK2 regulation? Pagano MA, see Sar§n eot a l Pagano MA, Sarno §S, Poletto G, Cozza G, Pinna LA, Meggio F: Autophosphorylation at the regulatory 6 subunit reflects the supramolecular organization of protein kinase CK2 Pinna LA, see Llorens F et a Pinna LA, see PaganoM A et al Pinna LA, see SarnSo e t Plana M, see LlorensF et ai PolettoG , see PagaMnA oet a Poole A, Poore T, Bandhakavi S,M cCann RO, Hanna DE, Glover CVC: A global view of CK2 function and regulation Poore T, see Poole A et a Pyerin W, see AckermaK netn a l Pyerin W, Barz T, Ackermann K: Protein kinase CK2 in gene control at cell cycle entry 189-200 Rasmussen T, Skjoth [HE, Jensen HH, Niefind K, Boldyreff B, Issinger O-G: Biochemical characterization of the recombinant human Drosophila homologues Timekeeper and Andante involved in the Drosophila circadian oscillator 151-161 Roher N, see Llorens F et a Ruzzene M, see SarnSo e f Sarno S, see Llorens F « SarnoS , see PagaMnA oet a Sarno S, Ruzzene M, Frascella P, Pagano MA, Meggio F, Zambon A, Mazzorana M, Maira GD, Lucchini V, Pinna LA: Devel- opment and exploitation of CK2 inhibitors Sarro E, see LlorensF et al SchettingS , see Gotz C et a Seldin DC, see Dominguez | ef a Seldin DC, Landesman-Bollag E, Farago M, Currier N, Lou D, Dominguez I: CK2 as a positive regulator of Wnt signalling and tumourigenesis Shatter J, see Karandikar UC eta l Skjoth LHE, see Rasmussen T eta l Slaton JW, see Wang G et al Souchier C, see Theis-Febvre N et al Symes K, see Dominguez | et al Tapia JC, see Hermosilla GH eta l Theis-Febvre N, Martel V, Laudet B, SouchierC , Grunwald D, Cochet C, Filhol O: Highlighting protein kinase CK2 movement in living cells Unger G, see Wang G et al Wang G, Ahmad KA, Ahmed K: Modulation of death receptor-mediated apoptosis by CK2 201 205 Wang G, Unger G, Ahmad KA, Slaton JW, Ahmed K: Downregulation of CK2 induces apoptosis in cancer cells — A potential approach to cancer therapy 77 84 Waxmann A, see Ackermann K et al Weber JE, see Olsten MEK et al Wu H, see Dominguez I et al Zambon A, see Sarno § et al